跳至主要内容
临床试验/JPRN-UMIN000008013
JPRN-UMIN000008013已完成未知

Safety and Efficacy of Autologous Myoblast Sheets Treatment for Patients with Severe Heart Failure due to Chronic ischemic Heart Disease. - Safety and Efficacy of Autologous Myoblast Sheets Treatment for Patients with Severe Heart Failure due to Chronic ischemic Heart Disease.

Terumo Corporation0 个研究点目标入组 6 人开始时间: 2012年5月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who have signs of skeletal muscle disease. (2) Patients under treatment with thyroid hormone. (3) Patients with infectious disease(HIV,HBV,HCV,HTLV1). (4) Patients in shock due to worsening heart failure. (5) Patients with intercurrent cardiovascular abnormalities that are judged to affect the clinical trial by the investigator or the sub investigators. (6) Patients with irreversible organ failure other than the heart. (7) Patients with a malignant tumor. (8) Patients who are pregnant or possibly pregnant. (9) Patients who cannot receive a blood transfusion. (10) Patients with a history of drug addiction or alcohol addiction within 6 months before obtaining informed consent.(11) Patients with hypersensitivity to antibiotics or animal origin materials such as fetal bovine serum. (12) Patients with severe pulmonary hypertension. (13) Patients with a history of other clinical study within 6 months. (14) Patients who are judged to be inappropriate for the study by the investigator or the sub investigators.

研究者

相似试验

Safety and Efficacy of Autologous Myoblast Sheets... | 临床试验